congenital syphilis

congenital syphilis
Name	Congenital syphilis
Caption	Treponema pallidum, the causative agent.
Field	Pediatrics, Infectious disease (medical specialty)

congenital syphilis is a severe, disabling, and often life-threatening infection seen in infants, transmitted from a mother to her fetus during pregnancy or Childbirth. The condition is caused by the spirochete bacterium Treponema pallidum, which crosses the placenta and can infect the developing fetus, leading to a wide spectrum of clinical manifestations. Without timely intervention, it can result in stillbirth, neonatal death, or chronic multi-organ disease in the child. The global burden of this condition remains a significant public health challenge, particularly in regions with limited access to prenatal care and sexually transmitted infection screening.

Signs and symptoms

Clinical presentation varies widely and is often categorized as early or late disease. Early manifestations, appearing within the first two years of life, may include snuffles (a mucopurulent rhinitis), a characteristic copper penny rash on the palms and soles, hepatosplenomegaly, lymphadenopathy, and osteochondritis. The Hutchinson triad, classically associated with late disease appearing after age two, consists of Hutchinson's teeth, interstitial keratitis, and eighth cranial nerve deafness. Other late stigmata include saber shins, frontal bossing of the skull, and Clutton's joints. Many infected infants are asymptomatic at birth, underscoring the critical need for systematic screening.

Causes and transmission

The sole cause is vertical transmission of Treponema pallidum subspecies pallidum from an infected mother to her fetus via the placenta. Transmission can occur during any stage of maternal syphilis, including primary, secondary, latent, and tertiary phases, though the risk is highest during early maternal infection. Transmission may also occur during passage through the birth canal if the mother has active genital lesions. The bacterium disseminates through the fetal circulatory system, invading multiple organs including the liver, bones, and central nervous system.

Diagnosis

Diagnosis relies on a combination of maternal history, clinical examination of the infant, and laboratory testing. The Centers for Disease Control and Prevention and the World Health Organization recommend serologic testing of both mother and infant using non-treponemal tests like the Venereal Disease Research Laboratory test or the rapid plasma reagin test, confirmed by treponemal tests such as the Treponema pallidum particle agglutination assay. Direct visualization of spirochetes from lesions or tissues using dark-field microscopy or silver stain provides definitive evidence. Evaluation should also include cerebrospinal fluid analysis, long bone radiographs, and a complete blood count.

Prevention

Prevention is entirely achievable through comprehensive prenatal care and routine serological screening of all pregnant women, as recommended by the American College of Obstetricians and Gynecologists. The cornerstone of prevention is adequate treatment of the infected mother with penicillin G during pregnancy, which is highly effective in preventing transmission to the fetus. Public health strategies, including partner notification and treatment through sexually transmitted disease clinics, are essential to break the chain of transmission. Initiatives by the World Health Organization aim for the global elimination of mother-to-child transmission.

Treatment

The treatment of choice for both infected mothers and infants is penicillin G. For infants with confirmed or highly probable disease, the recommended regimen is aqueous crystalline penicillin G intravenously or procaine penicillin G intramuscularly for 10 days. The Jarisch-Herxheimer reaction, an acute febrile reaction, can occur following initiation of therapy. Infants born to treated mothers require careful serologic follow-up to ensure declining non-treponemal antibody titers. Treatment of older children with late disease may require longer courses and management of specific sequelae by specialists in ophthalmology or otolaryngology.

Epidemiology

The epidemiology mirrors that of maternal syphilis. There has been a dramatic resurgence in many countries, including the United States, particularly in the Southern United States. Data from the Centers for Disease Control and Prevention show a sharp increase in reported cases in the 21st century. Disparities are stark, with higher rates observed among communities facing barriers to healthcare, including certain racial and ethnic groups and those in sub-Saharan Africa. The World Health Organization estimates a significant global burden, contributing substantially to perinatal mortality.

History

The disease has been recognized for centuries, with early descriptions often conflating it with other conditions. The term "congenital syphilis" was coined in the 19th century. The pioneering work of Jonathan Hutchinson in London meticulously detailed its late manifestations. The discovery of Treponema pallidum by Fritz Schaudinn and Erich Hoffmann in 1905 was a watershed moment. The development of the Wassermann test by August von Wassermann provided the first serologic diagnostic tool. The introduction of penicillin by Alexander Fleming, and its subsequent mass production during World War II, revolutionized treatment and prevention, offering the first reliable cure.

Category:Sexually transmitted diseases and infections Category:Pregnancy-related disorders Category:Pediatrics